Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
NCT01067287 · COMPLETED · Phase 2
We track 1 ClinicalTrials.gov studies led by Beth Israel Deaconess Medical Center. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Beth Israel Deaconess Medical Center.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Beth Israel Deaconess Medical Center currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Beth Israel Deaconess Medical Center conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.